Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
93 participants
INTERVENTIONAL
2023-02-20
2024-06-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
My Healthy Brain: Preserving and Promoting Brain Health Through Evidence-based Practices
NCT04537728
Improving Well-Being for Older Adult Family Dementia Caregivers
NCT03881631
Healthy Minds Comparison Study
NCT06282523
Behavioral Health Program for Short-Stay Nursing Facility Residents & Care Partners
NCT07220486
Student Wellness 2.0
NCT06804213
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To achieve our aims, we will conduct a single blind, pilot, feasibility, proof of concept randomized controlled trial (RCT) of HMP (12 weeks, \> 10 minutes daily) versus WA; 12 weeks, \>10 minutes daily). Assessments will be conducted at baseline, post program (12 weeks later) and at 20 weeks follow-up (\~2 months after post-test). Caregivers will also complete weekly assessments.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy Minds Program (HMP)
Participants assigned to the HMP group will be asked to practice 10 minutes per day for 12 weeks. The first four weeks will be prescribed. Weeks 5-12 will allow full access to the app's library.
Healthy Minds Program (HMP)
Participants assigned to the HMP group will be asked to complete a minimum of 10 minutes per day of meditation for 12 weeks. For the first four weeks, participants will listen to prescribed meditations that will teach them the foundations of mindfulness. During weeks 5-12, participants will have full access to the HMP meditation library.
Wellness App (WA)
Participants in the WA group will be asked to listen to the app content for 10 minutes per day for the entire 12 weeks.
Wellness App (WA)
Participants in the WA group will listen to a minimum of 10 minutes per day of a caregiver specific educational podcast (including topics such as "Caring for the Caregiver" or "Folate and Preventing Alzheimer's") delivered via a mobile app for the 12 weeks. The app contains one podcast per day for twelve weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Healthy Minds Program (HMP)
Participants assigned to the HMP group will be asked to complete a minimum of 10 minutes per day of meditation for 12 weeks. For the first four weeks, participants will listen to prescribed meditations that will teach them the foundations of mindfulness. During weeks 5-12, participants will have full access to the HMP meditation library.
Wellness App (WA)
Participants in the WA group will listen to a minimum of 10 minutes per day of a caregiver specific educational podcast (including topics such as "Caring for the Caregiver" or "Folate and Preventing Alzheimer's") delivered via a mobile app for the 12 weeks. The app contains one podcast per day for twelve weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. English fluency and literacy
3. Meeting criteria for being a caregiver (e.g., family or friend of a care recipient who provides unpaid care)
4. Perceived Stress Scale (4 items) version \>= 6
5. Willing to be randomized
6. Care recipient must score \>1 on the functional assessment scale (FAST)
Exclusion Criteria
2. Use of any consumer-based mindfulness meditation app for more than 60 min/month in the past 6 months.
3. Current participation in a meditation program (e.g., mindfulness-based stress reduction, mindfulness-base cognitive therapy, etc.)
4. Major illness known to worsen dramatically or require surgery in the next 20 weeks (study duration)
5. Active treatment for cancer (chemotherapy, radiation)
6. Imminent placement of care recipient in a nursing home or with another caregiver (within 4 months).
7. Involvement in another clinical trial for caregivers.
8. For participants age 65 and older: four or more errors on the Short Portable Mental Status questionnaire (SPMSQ)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ana-Maria Vranceanu, PhD
Associate Professor/Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ana-Maria Vranceanu, PhD
Role: PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital
Jennifer Huberty, PhD
Role: PRINCIPAL_INVESTIGATOR
Mays Cancer Center at UT Health San Antonio MD Anderson
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Massachusetts General Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Woodworth EC, Briskin EA, Plys E, Macklin E, Tatar RG, Huberty J, Vranceanu AM. Mindfulness-Based App to Reduce Stress in Caregivers of Persons With Alzheimer Disease and Related Dementias: Protocol for a Single-Blind Feasibility Proof-of-Concept Randomized Controlled Trial. JMIR Res Protoc. 2023 Oct 13;12:e50108. doi: 10.2196/50108.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022P001601
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.